v3.26.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 29, 2024   1,913,768,000        
Beginning balance at Dec. 29, 2024 $ 9,668 $ 19 $ 16,130 $ (242) $ (93) $ (6,146)
Beginning balance (in shares) at Dec. 29, 2024       11,208,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 1,140       1,140  
Other comprehensive loss 1,016         1,016
Cash dividends on common stock (in dollars per share) (1,183)       (1,183)  
Stock-based compensation 106   106      
Issuance of common stock under the Kenvue 2023 Plan, net (in shares)   11,142,000        
Issuance of common stock under the Kenvue 2023 Plan, net 84   84      
Purchase of treasury stock (in shares)   (9,179,000)   9,179,000    
Purchase of treasury stock (197)     $ (197)    
Ending balance (in shares) at Sep. 28, 2025   1,915,731,000        
Ending balance at Sep. 28, 2025 10,634 $ 19 16,320 $ (439) (136) (5,130)
Ending balance (in shares) at Sep. 28, 2025       20,387,000    
Beginning balance (in shares) at Jun. 29, 2025   1,918,837,000        
Beginning balance at Jun. 29, 2025 10,730 $ 19 16,288 $ (369) (136) (5,072)
Beginning balance (in shares) at Jun. 29, 2025       16,874,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 398       398  
Other comprehensive loss (58)         (58)
Cash dividends on common stock (in dollars per share) (398)       (398)  
Stock-based compensation 25   25      
Issuance of common stock under the Kenvue 2023 Plan, net (in shares)   407,000        
Issuance of common stock under the Kenvue 2023 Plan, net 7   7      
Purchase of treasury stock (in shares)   (3,513,000)   3,513,000    
Purchase of treasury stock (70)     $ (70)    
Ending balance (in shares) at Sep. 28, 2025   1,915,731,000        
Ending balance at Sep. 28, 2025 $ 10,634 $ 19 16,320 $ (439) (136) (5,130)
Ending balance (in shares) at Sep. 28, 2025       20,387,000    
Beginning balance (in shares) at Dec. 28, 2025 1,916,115,000 1,916,115,000        
Beginning balance at Dec. 28, 2025 $ 10,765 $ 19 16,348 $ (439) (204) (4,959)
Beginning balance (in shares) at Dec. 28, 2025 20,387,000     20,387,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 1,360       1,360  
Other comprehensive loss (449)         (449)
Cash dividends on common stock (in dollars per share) (1,603)       (1,603)  
Stock-based compensation 90   90      
Issuance of common stock under the Kenvue 2023 Plan, net (in shares)   4,765,000        
Issuance of common stock under the Kenvue 2023 Plan, net $ (1)   (1)      
Ending balance (in shares) at Sep. 27, 2026 1,920,879,688 1,920,880,000        
Ending balance at Sep. 27, 2026 $ 10,162 $ 19 16,437 $ (439) (447) (5,408)
Ending balance (in shares) at Sep. 27, 2026 20,387,000     20,387,000    
Beginning balance (in shares) at Jun. 28, 2026   1,920,241,000        
Beginning balance at Jun. 28, 2026 $ 10,553 $ 19 16,397 $ (439) (70) (5,354)
Beginning balance (in shares) at Jun. 28, 2026       20,387,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 430       430  
Other comprehensive loss (54)         (54)
Cash dividends on common stock (in dollars per share) (807)       (807)  
Stock-based compensation 29   29      
Issuance of common stock under the Kenvue 2023 Plan, net (in shares)   639,000        
Issuance of common stock under the Kenvue 2023 Plan, net $ 11   11      
Ending balance (in shares) at Sep. 27, 2026 1,920,879,688 1,920,880,000        
Ending balance at Sep. 27, 2026 $ 10,162 $ 19 $ 16,437 $ (439) $ (447) $ (5,408)
Ending balance (in shares) at Sep. 27, 2026 20,387,000     20,387,000